Vericel Corp Ord Stock Current Valuation
| VCEL Stock | USD 58.14 0.38 0.66% |
Valuation analysis of Vericel Corp Ord helps investors to measure Vericel Corp's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Over EBITDA is expected to rise to 628.29 this year. Enterprise Value Multiple is expected to rise to 628.29 this year. Fundamental drivers impacting Vericel Corp's valuation include:
Price Book 11.0728 | Enterprise Value 2.8 B | Enterprise Value Ebitda 272.6696 | Price Sales 12.5678 | Forward PE 109.8901 |
Overvalued
Today
Please note that Vericel Corp's price fluctuation is very steady at this time. Calculation of the real value of Vericel Corp Ord is based on 3 months time horizon. Increasing Vericel Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Vericel stock is determined by what a typical buyer is willing to pay for full or partial control of Vericel Corp Ord. Since Vericel Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Vericel Stock. However, Vericel Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 58.14 | Real 47.46 | Target 41.08 | Hype 58.44 |
The intrinsic value of Vericel Corp's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Vericel Corp's stock price.
Estimating the potential upside or downside of Vericel Corp Ord helps investors to forecast how Vericel stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Vericel Corp more accurately as focusing exclusively on Vericel Corp's fundamentals will not take into account other important factors: Vericel Corp Ord Company Current Valuation Analysis
Vericel Corp's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Vericel Corp Current Valuation | 2.85 B |
Most of Vericel Corp's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vericel Corp Ord is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Vericel Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Vericel Corp is extremely important. It helps to project a fair market value of Vericel Stock properly, considering its historical fundamentals such as Current Valuation. Since Vericel Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vericel Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vericel Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
Vericel Current Valuation Historical Pattern
Today, most investors in Vericel Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Vericel Corp's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Vericel Corp current valuation as a starting point in their analysis.
Vericel Corp Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Vericel Corp Ord has a Current Valuation of 2.85 B. This is 80.18% lower than that of the Biotechnology sector and 38.72% lower than that of the Health Care industry. The current valuation for all United States stocks is 82.88% higher than that of the company.
Vericel Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vericel Corp's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vericel Corp could also be used in its relative valuation, which is a method of valuing Vericel Corp by comparing valuation metrics of similar companies.Vericel Corp is currently under evaluation in current valuation category among its peers.
Vericel Corp ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Vericel Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Vericel Corp's managers, analysts, and investors.Environmental | Governance | Social |
Vericel Fundamentals
| Return On Equity | 0.0154 | ||||
| Return On Asset | -0.0022 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 2.85 B | ||||
| Shares Outstanding | 49.36 M | ||||
| Shares Owned By Insiders | 0.92 % | ||||
| Shares Owned By Institutions | 99.08 % | ||||
| Number Of Shares Shorted | 3.7 M | ||||
| Price To Earning | 357.33 X | ||||
| Price To Book | 11.07 X | ||||
| Price To Sales | 12.57 X | ||||
| Revenue | 197.52 M | ||||
| Gross Profit | 109.79 M | ||||
| EBITDA | 2.86 M | ||||
| Net Income | (3.18 M) | ||||
| Cash And Equivalents | 100.69 M | ||||
| Cash Per Share | 2.13 X | ||||
| Total Debt | 88.14 M | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 6.20 X | ||||
| Book Value Per Share | 5.23 X | ||||
| Cash Flow From Operations | 35.31 M | ||||
| Short Ratio | 8.92 X | ||||
| Earnings Per Share | 0.08 X | ||||
| Target Price | 61.5 | ||||
| Number Of Employees | 314 | ||||
| Beta | 1.67 | ||||
| Market Capitalization | 2.85 B | ||||
| Total Asset | 353.66 M | ||||
| Retained Earnings | (403.18 M) | ||||
| Working Capital | 159.88 M | ||||
| Current Asset | 21.1 M | ||||
| Current Liabilities | 15.36 M | ||||
| Net Asset | 353.66 M |
About Vericel Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vericel Corp Ord's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vericel Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vericel Corp Ord based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Vericel Corp Piotroski F Score and Vericel Corp Altman Z Score analysis. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.045 | Earnings Share 0.08 | Revenue Per Share 4.685 | Quarterly Revenue Growth 0.27 | Return On Assets (0) |
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.